A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in mice.
Sign Up to like & getrecommendations! Published in 2020 at "Vaccine"
DOI: 10.1016/j.vaccine.2020.08.066
Abstract: Vaccine development for antigenically variable pathogens has faltered because extreme genetic diversity precludes induction of broadly neutralizing antibodies (nAB) with classical vaccines. Here, using the most variable epitope of any known human pathogen (HVR1 of… read more here.
Keywords: neutralizing antibodies; bivalent hcv; pan genotypic; vaccine ... See more keywords